Buy or Sell

Your top ASX stocks, analysed by the experts

Buy or Sell

Show Notes

In this episode, we put your most requested ASX stocks under the microscope.

You voted for the companies you wanted reviewed, and Henry Jennings (Marcus Today) and Julia Weng (Paradice Investment Management) delivered their buy or sell verdicts on names including CBA, CSL, ResMed, Fortescue, TechnologyOne and more.

Stocks Mentioned: Soul Patts (ASX: SOL) ResMed (ASX: RMD) CSL Limited (ASX: CSL) Aristocrat Leisure (ASX: ALL) Technology One (ASX: TNE) Fortescue (ASX: FMG) Commonwealth Bank (ASX: CBA)

Chapters: 00:00 Introduction 01:09 Soul Patts: Premium Worth Paying? 02:53 ResMed: Henry Turns Bullish 04:37 CSL: Is It Back? 07:18 Aristocrat: Quality Versus Ethics 09:57 Technology One Divides Opinion 12:23 Fortescue: Cheap Enough Yet? 15:01 CBA: Buy the Dip?

This episode was recorded on the 19th August 2026.

———

Thanks to bitcoin.com.au for sponsoring Buy or Sell. To claim your new financial year offer, head to bitcoin.com.au/equitymates.

Disclaimer: This is general information only, not financial advice. Cryptocurrency is volatile, capital is at risk, and you should consider your own circumstances before investing.

A big thank you to our sponsor bitcoin.com.au for helping to keep our content free.

———

Want more Equity Mates? Across books, podcasts, video and email, however you want to learn about investing – we’ve got you covered. Keep up with the news moving markets with our daily newsletter and podcast (Apple | Spotify) Want more from Buy or Sell host Ally? Check out Basis Points

Listen to the podcast (Apple | Spotify) Watch on YouTube Subscribe to the weekly email

———

In the spirit of reconciliation, Equity Mates Media and the hosts of Equity Mates Investing acknowledge the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander people today.

———

Buy or Sell is a product of Equity Mates Media.

This podcast is intended for education and entertainment purposes only. Any advice is general advice, and has not taken into account your personal financial circumstances. Before acting on general advice, you should consider if it is relevant to your needs. If you are unsure, please speak to a financial professional. The hosts of this podcast and their guests may have positions in the companies mentioned. Equity Mates Media is part of the Betashares group but maintains editorial independence.

Equity Mates Media operates under Australian Financial Services Licence 540697. Buy or Sell is a product of Equity Mates Media.

This podcast is intended for education and entertainment purposes. Any advice is general advice only, and has not taken into account your personal financial circumstances, needs or objectives. Before acting on general advice, you should consider if it is relevant to your needs and read the relevant Product Disclosure Statement. And if you are unsure, please speak to a financial professional.

Equity Mates Media operates under Australian Financial Services Licence 540697. Hosted on Acast. See acast.com/privacy for more information.

More from Buy or Sell

Oct 15, 2026

With rate hikes on everyone’s minds and wallets - today’s guests think we should already be positioning our portfolios for cuts.

Oct 8, 2026

Which Aussie mining stocks are benefiting big from AI and robotics? We asked two expert for their take.

Oct 1, 2026

Are these 3 heavily shorted ASX stocks ripe for opportunity?

Sep 24, 2026

How would you build an income portfolio with just three ETFs?

Sep 17, 2026

You picked them, these experts are rating them.

See all episodes →